CurrentRheuma
Get Weekly

Topic · page 21 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 801–840 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

  1. Arthritis Res Ther

    Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

    Secondary analysis

  2. Arthritis Res Ther

    Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis

    Cohort study

  3. Arthritis Res Ther

    Patients with radiographic axial spondylarthritis have an impaired dietary intake—a cross-sectional study with matched controls from northern Sweden

    Cross-sectional study

  4. Arthritis Res Ther

    Role of inflammatory burden and treatment on joint space width in psoriatic arthritis—a high-resolution peripheral quantitative computed tomography study

    Cross-sectional study

  5. Ann Rheum Dis

    Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis

    Mechanistic study

  6. Arthritis Res Ther

    Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort

    Cross-sectional study

  7. J Rheumatol

    Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting

    Research article

  8. J Rheumatol

    Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis

    Research article

  9. RMD Open

    Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years

    Cohort study

  10. RMD Open

    The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials

    Meta-analysis

  11. Rheumatology (Oxford)

    Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication

    Cohort study

  12. Arthritis Res Ther

    Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention

    Cohort study

  13. Arthritis Rheumatol

    Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin‐4/13 Inhibitor

    Cohort study

  14. RMD Open

    Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study

    Secondary analysis

  15. J Rheumatol

    Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients

    Cross-sectional study

  16. J Rheumatol

    Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry

    Cross-sectional study

  17. Clin Exp Rheumatol

    Depression as a possible determinant of fatigue in patients with axial spondyloarthritis

    Cross-sectional study

  18. J Rheumatol

    Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

    Guideline or statement

  19. J Rheumatol

    Advances in the Evaluation of Peripheral Enthesitis by Magnetic Resonance Imaging in Patients With Psoriatic Arthritis

    Guideline or statement

  20. J Rheumatol

    Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?

    Research article

  21. J Rheumatol

    GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis

    Guideline or statement

  22. RMD Open

    Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial

    Secondary analysis

  23. Joint Bone Spine

    Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort

    Cohort study

  24. Semin Arthritis Rheum

    The value of correctly diagnosing axial spondyloarthritis for patients and society

    Research article

  25. Semin Arthritis Rheum

    Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers

    Cohort study

  26. J Rheumatol

    Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study

    Cohort study

  27. Clin Exp Rheumatol

    'Double target' ultrasound monitoring of biologic therapy in psoriatic arthritis

    Cohort study

  28. Semin Arthritis Rheum

    Insights into suicidal behavior among psoriatic arthritis patients: A systematic review and a genetic linkage disequilibrium analysis

    Meta-analysis

  29. Clin Exp Rheumatol

    Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations

    Meta-analysis

  30. Rheumatology (Oxford)

    The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study

    Case-control study

  31. Arthritis Res Ther

    Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

    Cohort study

  32. Arthritis Res Ther

    More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease

    Cross-sectional study

  33. RMD Open

    Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce

    Meta-analysis

  34. Arthritis Rheumatol

    Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial

    Randomized controlled trial

  35. Clin Exp Rheumatol

    IL-17-producing cells in ankylosing spondylitis patients show gender-based differences in gene expression

    Mechanistic study

  36. Rheumatology (Oxford)

    The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study

    Diagnostic or prognostic study

  37. Scand J Rheumatol

    Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study

    Cohort study

  38. Scand J Rheumatol

    Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study

    Cross-sectional study

  39. RMD Open

    Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis

    Diagnostic or prognostic study

  40. Rheumatology (Oxford)

    Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

    Diagnostic or prognostic study

All 1,039 Briefs in ExploreShowing Briefs 801–840 of 1,039, newest first